National Organization for Rare Disorders and OpenEvidence Partner to Bring AI-Powered Rare Disease Resources to Clinicians and Patients Worldwide
The National Organization for Rare Disorders (NORD®) and OpenEvidence today announced a new partnership to expand access to trusted, expert-reviewed rare disease information for clinicians, patients and families.
Sutter Health Collaborates with OpenEvidence to Bring Evidence-Based, AI-Powered Insights into Physician Workflows
Sutter Health and OpenEvidence are teaming up to deliver the latest medical data and information to doctors working within electronic health records. This collaboration will help Sutter clinicians quickly find and use up-to-date clinical information – helping the system meet its high standards for quality, safety and patient-centered care.
OpenEvidence Raises $250 Million to Build Medical Superintelligence for Doctors
OpenEvidence, the most widely-used AI platform by doctors in America, announced today that it closed a Series D round of funding, valuing the company at $12 billion. This makes OpenEvidence the most valuable Healthcare AI company in the world.
